As an example of therapeutic repurposing, the HER2-amplified breast cancer treatment trastuzumab (Herceptin) has been shown to be effective in advanced gastric cancer, and potentially HER2 amplified pancreatic ductal adenocarcinoma23,24. This evidence concerns the gene ERBB2 and breast carcinoma.